Revasum Inc (ASX:RVS)
A$ 0.115 0 (0%) Market Cap: 14.73 Mil Enterprise Value: 14.73 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 19/100

Q4 2019 Revasum Inc Earnings Call Transcript

Jan 28, 2020 / 11:00PM GMT
Release Date Price: A$0.80991 (-4.65%)
Operator

(technical difficulty)

Ryan A. Benton;Jerauld J.
Revasum, Inc. - Senior VP, CFO, Company Secretary & Executive Director

Operator. Good morning, everyone. Before we begin, I remind everyone that during the course of this conference call, we will be making forward-looking statements that involve a number of risks and uncertainties that are not guarantees of future performance or results. You are encouraged to review the safe harbor and disclaimer statements contained in today's materials as well as the other risks detailed from time to time in the company's regulatory filings with the ASX.

I would also like to highlight that the numbers published in our release and discussed here today are unaudited. Additionally, I will note that our Q4 Appendix 4C, along with our full year financial statements for FY '19, once published, are through the date of January 5, 2020, as the company recently changed its fiscal year end date to be -- to adopt a 5-4-4 manufacturing calendar. And with that, I'd like to turn the call over to Jerry. Jerry?

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot